Skip to main content
. Author manuscript; available in PMC: 2019 Oct 9.
Published in final edited form as: Infect Control Hosp Epidemiol. 2016 Jul 26;37(11):1323–1330. doi: 10.1017/ice.2016.156

Table 3:

Comparison of percentages of positive surveillance screening for MRSA and VRE before and after the CP policy change.

Before CP were discontinued After CP were discontinued P value
MRSA Nasal Swabs % Positive 4.5% 4.9% 0.255
n 11641 11543
VRE Rectal Swabs % Positive 31.7% 22.6% 0.084
n 1045 84